Skip to main content
. 2017 Feb 24;8(20):32769–32782. doi: 10.18632/oncotarget.15680

Figure 6. SerpinB2 overexpression is associated with unfavorable BC patient survival outcomes.

Figure 6

OS analysis by high or low SerpinB2 protein level in patient primary tumors (A) OS analysis in high and low SerpinB2-expressing cases in patients with (B) or without (C) LN metastasis.